Israel Englander Aquestive Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 90,862 shares of AQST stock, worth $465,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,862
Previous 494,445
81.62%
Holding current value
$465,213
Previous $2.11 Million
88.79%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
43.1MCall Options Held
271KPut Options Held
212K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$50.2 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$28.4 Million1.58% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$27.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.23MShares$21.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.85MShares$14.6 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $273M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...